pubmed-article:14662257 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14662257 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:14662257 | lifeskim:mentions | umls-concept:C0012265 | lld:lifeskim |
pubmed-article:14662257 | lifeskim:mentions | umls-concept:C0018801 | lld:lifeskim |
pubmed-article:14662257 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
pubmed-article:14662257 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
pubmed-article:14662257 | lifeskim:mentions | umls-concept:C0054836 | lld:lifeskim |
pubmed-article:14662257 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
pubmed-article:14662257 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
pubmed-article:14662257 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:14662257 | pubmed:dateCreated | 2003-12-9 | lld:pubmed |
pubmed-article:14662257 | pubmed:abstractText | This study examined the relative merits of digoxin, carvedilol, and their combination for the management of patients with atrial fibrillation (AF) and heart failure (HF). | lld:pubmed |
pubmed-article:14662257 | pubmed:language | eng | lld:pubmed |
pubmed-article:14662257 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14662257 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:14662257 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14662257 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14662257 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14662257 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14662257 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14662257 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14662257 | pubmed:month | Dec | lld:pubmed |
pubmed-article:14662257 | pubmed:issn | 0735-1097 | lld:pubmed |
pubmed-article:14662257 | pubmed:author | pubmed-author:ClelandJohn... | lld:pubmed |
pubmed-article:14662257 | pubmed:author | pubmed-author:MartinWilliam... | lld:pubmed |
pubmed-article:14662257 | pubmed:author | pubmed-author:TaylorJacquel... | lld:pubmed |
pubmed-article:14662257 | pubmed:author | pubmed-author:RankinAndrew... | lld:pubmed |
pubmed-article:14662257 | pubmed:author | pubmed-author:GemmellIslayI | lld:pubmed |
pubmed-article:14662257 | pubmed:author | pubmed-author:KhandAleem... | lld:pubmed |
pubmed-article:14662257 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14662257 | pubmed:day | 3 | lld:pubmed |
pubmed-article:14662257 | pubmed:volume | 42 | lld:pubmed |
pubmed-article:14662257 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14662257 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14662257 | pubmed:pagination | 1944-51 | lld:pubmed |
pubmed-article:14662257 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:meshHeading | pubmed-meshheading:14662257... | lld:pubmed |
pubmed-article:14662257 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14662257 | pubmed:articleTitle | Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? | lld:pubmed |
pubmed-article:14662257 | pubmed:affiliation | Academic Unit of Cardiology, University of Hull, Kingston-Upon-Hull, United Kingdom. | lld:pubmed |
pubmed-article:14662257 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14662257 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:14662257 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:14662257 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:14662257 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:14662257 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
pubmed-article:14662257 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14662257 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14662257 | lld:pubmed |